Hospitalization for Acute Respiratory Tract Infection in a Low-Antibiotic-Prescribing Setting: Cross-Sectional Data from General Practice.
anti-bacterial agents
drug prescriptions
inappropriate prescribing
primary health care
respiratory tract infections
Journal
Antibiotics (Basel, Switzerland)
ISSN: 2079-6382
Titre abrégé: Antibiotics (Basel)
Pays: Switzerland
ID NLM: 101637404
Informations de publication
Date de publication:
29 Sep 2020
29 Sep 2020
Historique:
received:
19
08
2020
revised:
24
09
2020
accepted:
24
09
2020
entrez:
2
10
2020
pubmed:
3
10
2020
medline:
3
10
2020
Statut:
epublish
Résumé
Acute respiratory tract infections (ARTI) are the main cause of inappropriate antibiotic prescribing. To date, there is limited evidence concerning whether low levels of antibiotic prescribing may impact patient safety. We investigate whether antibiotic prescribing for patients seeking primary care for ARTI correlates with the odds for hospitalization. Analysis of patient baseline data ( Neither the antibiotic status of individual patients (OR 0.91; 95% CI: 0.49 to 1.69; In a low-antibiotic-prescribing primary care setting such as Germany, lack of treatment with antibiotics for ARTI did not result in higher odds for hospitalization in an adult population.
Sections du résumé
BACKGROUND
BACKGROUND
Acute respiratory tract infections (ARTI) are the main cause of inappropriate antibiotic prescribing. To date, there is limited evidence concerning whether low levels of antibiotic prescribing may impact patient safety. We investigate whether antibiotic prescribing for patients seeking primary care for ARTI correlates with the odds for hospitalization.
METHODS
METHODS
Analysis of patient baseline data (
RESULTS
RESULTS
Neither the antibiotic status of individual patients (OR 0.91; 95% CI: 0.49 to 1.69;
CONCLUSIONS
CONCLUSIONS
In a low-antibiotic-prescribing primary care setting such as Germany, lack of treatment with antibiotics for ARTI did not result in higher odds for hospitalization in an adult population.
Identifiants
pubmed: 33003436
pii: antibiotics9100653
doi: 10.3390/antibiotics9100653
pmc: PMC7600502
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Bundesministerium für Bildung und Forschung
ID : BMBF 01GY1140
Références
BMJ. 2017 May 22;357:j2148
pubmed: 28533265
Cochrane Database Syst Rev. 2017 Jun 19;6:CD000245
pubmed: 28626858
Lancet Infect Dis. 2013 Feb;13(2):123-9
pubmed: 23265995
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013 Mar;56(3):447-54
pubmed: 23334292
Cochrane Database Syst Rev. 2015 Nov 12;(11):CD010907
pubmed: 26560888
BMJ. 2016 Jul 04;354:i3410
pubmed: 27378578
BMJ. 1998 Sep 5;317(7159):637-42
pubmed: 9727992
Implement Sci. 2018 Mar 20;13(1):47
pubmed: 29554972
BMC Fam Pract. 2012 Dec 20;13:124
pubmed: 23256712
J Antimicrob Chemother. 2011 Dec;66 Suppl 6:vi3-12
pubmed: 22096064
BMJ. 2009 Jun 23;338:b2242
pubmed: 19549995
Gastroenterol Clin North Am. 2017 Mar;46(1):61-76
pubmed: 28164853
Respir Med. 2004 Jan;98(1):17-24
pubmed: 14959809
Qual Saf Health Care. 2007 Dec;16(6):440-5
pubmed: 18055888
Cochrane Database Syst Rev. 2013 Jun 04;(6):CD000247
pubmed: 23733381
Lancet. 2005 Feb 12-18;365(9459):579-87
pubmed: 15708101
Scand J Prim Health Care. 1997 Sep;15(3):118-22
pubmed: 9323777
JAMA. 1997 Sep 17;278(11):901-4
pubmed: 9302241
Cochrane Database Syst Rev. 2017 Sep 07;9:CD004417
pubmed: 28881007